CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes

Tarih

Yazarlar

Schnell, Oliver

Battelino, Tadej

Bergenstal, Richard

Birkenfeld, Andreas L.

Ceriello, Antonio

Davies, Melanie

Giorgino, Francesco

DOI No

10.1186/s12933-023-01788-6

Diğer Tanımlayıcı No

WOS:000954649400001

Yayınevi

Anahtar kelimeler

Cardiovascular disease, Chronic kidney disease, Diabetes, GIP, GLP\\-1 receptor agonist, Heart failure, Obesity, SGLT2 inhibitor

URI

https://openaccess.acibadem.edu.tr/handle/11443/6529

Koleksiyonlar

Tam öğe sayfası